Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature.

TitleIntracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature.
Publication TypeJournal Article
Year of Publication2005
AuthorsLuther N, Greenfield JP, Chadburn A, Schwartz TH
JournalJ Neurooncol
Volume75
Issue2
Pagination185-8
Date Published2005 Nov
ISSN0167-594X
KeywordsAdult, Anti-Bacterial Agents, CD3 Complex, CD4 Antigens, CD56 Antigen, Craniotomy, Fatal Outcome, Follow-Up Studies, Humans, Immunophenotyping, Killer Cells, Natural, Lymphoma, T-Cell, Magnetic Resonance Imaging, Male, Nose Neoplasms, Pseudomonas aeruginosa, Staphylococcus aureus, Time Factors
Abstract

Advances in immunophenotypic profiling now permit characterization of natural killer/T-cell (NK/T-cell) lymphoma as distinct from other extranodal T- and B-cell Non-Hodgkin's lymphomas. NK/T-cell lymphoma presents most commonly in the nasal cavity. Disease progression to the central nervous system (CNS) is a rare phenomenon. We present here, to our knowledge, the first immunophenotypically-confirmed case of direct extension of nasal NK/T-cell lymphoma to the brain. In addition, we review the literature with respect to NK/T-cell lymphoma metastasis to the CNS. The overall prevalence of NK/T-cell lymphoma CNS metastasis is less than 3%. Although rare, CNS invasion portends a poor prognosis, emphasizing the importance of early and accurate immunophenotype profiling and the need for novel, aggressive therapy.

DOI10.1007/s11060-005-1862-z
Alternate JournalJ Neurooncol
PubMed ID16283442
Related Faculty: 
Amy Chadburn, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700